Timothy J Iveson (Tim Iveson, Timothy Iveson)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Topics

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JNCI cancer spectrum

Health technology assessment (Winchester, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Enric Domingo, Caroline A Kelly, Jennifer Hay, Owen Sansom, Noori Maka, Karin Oien, Timothy J Iveson, Mark Saunders, Rachel Kerr, Ian Tomlinson, Joanne Edwards, Andrea Harkin, Marta Nowak, Viktor Hendrik Koelzer, Alistair Easton, Ioannis Boukovinas, Eleni Moustou, Ippokratis Messaritakis, Maria Chondrozoumaki, Michaela Karagianni, Franck Pagès, Fanny Arnoux, Christelle Lautard, Yoann Lovera, Isabelle Boquet, Aurelie Catteau, Jerome Galon, null null, Ioannis Souglakos, David N Church
Prognostic and Predictive Value of Immunoscore in Stage III Colorectal Cancer: Pooled Analysis of Cases From the SCOT and IDEA-HORG Studies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (18) (2024)
Enric Domingo, Caroline A Kelly, Jennifer Hay, Owen Sansom, Noori Maka, Karin Oien, Timothy J Iveson, Mark Saunders, Rachel Kerr, Ian Tomlinson, Joanne Edwards, Andrea Harkin, Marta Nowak, Viktor Hendrik Koelzer, Alistair Easton, Ioannis Boukovinas, Eleni Moustou, Ippokratis Messaritakis, Maria Chondrozoumaki, Michaela Karagianni, Franck Pagès, Fanny Arnoux, Christelle Lautard, Yoann Lovera, Isabelle Boquet, Aurelie Catteau, Jerome Galon, null null, Ioannis Souglakos, David N Church
Prognostic and Predictive Value of Immunoscore in Stage III Colorectal Cancer: Pooled Analysis of Cases From the SCOT and IDEA-HORG Studies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Enric Domingo, Caroline A Kelly, Jennifer Hay, Owen Sansom, Noori Maka, Karin Oien, Timothy J Iveson, Mark Saunders, Rachel Kerr, Ian Tomlinson, Joanne Edwards, Andrea Harkin, Marta Nowak, Viktor Hendrik Koelzer, Alistair Easton, Ioannis Boukovinas, Eleni Moustou, Ippokratis Messaritakis, Maria Chondrozoumaki, Michaela Karagianni, Franck Pagès, Fanny Arnoux, Christelle Lautard, Yoann Lovera, Isabelle Boquet, Aurelie Catteau, Jerome Galon, null null, Ioannis Souglakos, David N Church
Prognostic and Predictive Value of Immunoscore in Stage III Colorectal Cancer: Pooled Analysis of Cases From the SCOT and IDEA-HORG Studies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (18) (2024)
Claire Gallois, Qian Shi, Levi D Pederson, Thierry André, Timothy J Iveson, Alberto F Sobrero, Steven R Alberts, Aimery deGramont, Jeffrey A Meyerhardt, Thomas J George, Hans-Joachim E Schmoll, Ioannis Souglakos, Andrea Harkin, Roberto Labianca, Frank A Sinicrope, Eiji Oki, Anthony Frank Shields, Ioannis Boukovinas, Rachel Kerr, Sara Lonardi, Greg Yothers, Takayuki Yoshino, Richard M Goldberg, Gilles Manceau, Demetris Papamichael
Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (19) (2024)
Claire Gallois, Qian Shi, Levi D Pederson, Thierry André, Timothy J Iveson, Alberto F Sobrero, Steven R Alberts, Aimery deGramont, Jeffrey A Meyerhardt, Thomas J George, Hans-Joachim E Schmoll, Ioannis Souglakos, Andrea Harkin, Roberto Labianca, Frank A Sinicrope, Eiji Oki, Anthony Frank Shields, Ioannis Boukovinas, Rachel Kerr, Sara Lonardi, Greg Yothers, Takayuki Yoshino, Richard M Goldberg, Gilles Manceau, Demetris Papamichael
Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Enric Domingo, Caroline A Kelly, Jennifer Hay, Owen Sansom, Noori Maka, Karin Oien, Timothy J Iveson, Mark Saunders, Rachel Kerr, Ian Tomlinson, Joanne Edwards, Andrea Harkin, Marta Nowak, Viktor Hendrik Koelzer, Alistair Easton, Ioannis Boukovinas, Eleni Moustou, Ippokratis Messaritakis, Maria Chondrozoumaki, Michaela Karagianni, Franck Pagès, Fanny Arnoux, Christelle Lautard, Yoann Lovera, Isabelle Boquet, Aurelie Catteau, Jerome Galon, null null, Ioannis Souglakos, David N Church
Prognostic and Predictive Value of Immunoscore in Stage III Colorectal Cancer: Pooled Analysis of Cases From the SCOT and IDEA-HORG Studies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (18) (2024)
Claire Gallois, Qian Shi, Jeffrey P Meyers, Timothy J Iveson, Steven R Alberts, Aimery deGramont, Alberto F Sobrero, Daniel G Haller, Eiji Oki, Anthony Frank Shields, Richard M Goldberg, Rachel Kerr, Sara Lonardi, Greg Yothers, Caroline Kelly, Ioannis Boukovinas, Roberto Labianca, Frank A Sinicrope, Ioannis Souglakos, Takayuki Yoshino, Jeffrey A Meyerhardt, Thierry André, Demetris Papamichael, Gilles Manceau
Prognostic Impact of Early Treatment and Oxaliplatin Discontinuation in Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 11 Adjuvant Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
John A Bridgewater, Peter Fletcher, Daniel H Palmer, Hassan Z Malik, K Raj Prasad, Darius F Mirza, Alan Anthony, Philippa Corrie, Stephen Falk, Meg Finch-Jones, Harpreet S Wasan, Paul J Ross, Lucy Wall, Jonathan Wadsley, Thomas R Evans, Deborah Stocken, Clive Stubbs, Raaj Praseedom, Yuk Ting Ma, Brian R Davidson, John P Neoptolemos, Timothy J Iveson, David Cunningham, O James Garden, Juan W Valle, John N Primrose, null null
Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (18) (2022)
Timothy J Iveson, Alberto F Sobrero, Takayuki Yoshino, Ioannis Souglakos, Fang-Shu Ou, Jeffrey P Meyers, Qian Shi, Axel Grothey, Mark P Saunders, Roberto Labianca, Takeharu Yamanaka, Ioannis Boukovinas, Niels Henrik Hollander, Fabio Galli, Kentaro Yamazaki, Vassilis Georgoulias, Rachel Kerr, Eiji Oki, Sara Lonardi, Andrea Harkin, Gerardo Rosati, James Paul
Duration of Adjuvant Doublet Chemotherapy (3 or 6 months) in Patients With High-Risk Stage II Colorectal Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (6) (2021)
Elisa Fontana, Jeff Meyers, Alberto F Sobrero, Timothy J Iveson, Anthony F Shields, Gilles Manceau, Takayuki Yoshino, Ioannis Souglakos, Elizabeth C Smyth, Florian Lordick, Markus Möhler, Anne Giraut, Andrea Harkin, Roberto Labianca, Jeffrey Meyerhardt, Thierry André, Ioannis Boukovinas, Sara Lonardi, Mark Saunders, Dewi Vernerey, Eiji Oki, Vassilis Georgoulias, Irit Ben-Aharon, Qian Shi
Early-Onset Colorectal Adenocarcinoma in the IDEA Database: Treatment Adherence, Toxicities, and Outcomes With 3 and 6 Months of Adjuvant Fluoropyrimidine and Oxaliplatin. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Prunella L Blinman, Andrew James Martin, Michael Jefford, David Goldstein, David Boadle, Michelle Morris, Niall Tebbutt, Christine Aiken, Andrea Harkin, Eva Segelov, Andrew Haydon, Timothy J Iveson, Martin R Stockler
Patients' Preferences for 3 Months vs 6 Months of Adjuvant Chemotherapy for Colon Cancer. JNCI cancer spectrum 5 (1) (2020)
Timothy J Iveson, Kathleen Anne Boyd, Rachel S Kerr, Jose Antonio Robles-Zurita, Mark P Saunders, Andrew H Briggs, Jim Cassidy, Niels Henrik Hollander, Josep Tabernero, Andrew Haydon, Bengt Glimelius, Andrea Harkin, Karen Allan, John McQueen, Sarah Pearson, Ashita Waterston, Louise Medley, Charles Wilson, Richard Ellis, Sharadah Essapen, Amandeep S Dhadda, Mark Harrison, Stephen Falk, Sherif Raouf, Charlotte Rees, Rene K Olesen, David J Propper, John A Bridgewater, Ashraf Azzabi, David Farrugia, Andrew Webb, David Cunningham, Tamas Hickish, Andrew Weaver, Simon Gollins, Harpreet S Wasan, James Paul
3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT. Health technology assessment (Winchester, England) 23 (64) (2020)